Towards an integrated treatment of depression;Verso un trattamento integrato della depressione

Rivista di Psichiatria

Volumn 37, Issue 6, 2002, Pages 284-289

  Picardi, Angelo ^a   Biondi, Massimo ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Depression; Drug treatment; Integration; Psychosomatics; Psychotherapy

Indexed keywords

ANTIDEPRESSANT AGENT;

DEPRESSION; DISEASE COURSE; DRUG WITHDRAWAL; HUMAN; PSYCHOSOMATICS; PSYCHOTHERAPY; RECURRENT DISEASE; RELAPSE; REVIEW;

EID: 0036865156     PISSN: 00356484     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Regier DA, Narrow WE, Rae DE, Manderscheid RW, Locke BZ, Goodwin FK: The de facto U.S. mental and addictive disorders service system. Archives of General Psychiatry, 1993, 50, 85-94.
2. Horwath E, Weismann MM: Epidemiology of depression and anxiety disorders. In: Textbook in Psychiatric Epidemiology (Tsuang MT, Tohen M, Zahner GEP, eds). New York, John Wiley & Sons, 1995, 317-344.
3. Faravelli C, Degl'Innocenti BG, Aiazzi A, Incerpi G, Pallanti S: Epidemiology of mood disorders: A community survey in Florence. Journal of Affective Disorders, 1990, 20, 135-141.
4. Üstün TB: The global burden of mental disorders. American Journal of Public Health 1999, 89, 1315-1318.
5. Hays RD, Wells KB, Sherbourne CD, Rogers W, Spritzer K: Functioning and well-being outcomes of patients with depression compared with chronic general medical illness. Archives of General Psychiatry 1995, 52, 11-19.
6. Ormel J, VonKorff M, Ustun B, Pini S, Korten A, Oldehinkel T: Common mental disorders and disability across cultures: Results from the WHO collaborative study on psychological problems in general health care. JAMA 1994, 272, 1741-1748.
7. Murray CJ, Lopez AD: Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997, 349, 1498-1504.
8. Piccinelli M, Wilkinson G: Outcome of depression in psychiatric settings. British Journal of Psychiatry 1994, 164, 297-304.
9. Maj M, Vetro F, Pirozzi R, Lobrace S, Magliano L: Pattern of recurrence of illness after recovery from an episode of major depression: A prospective study. American Journal of Psychiatry 1992, 149, 795-800.
10. Viguera AC, Baldessarini RJ, Friedberg J: Discontinuing antidepressant treatment in major depression. Harvard Review of Psychiatry 1998, 5, 293-306.
11. Fava GA: Long-term treatment with antidepressant drugs: The spectacular achievements of propaganda. Psychotherapy and Psychosomatics 2002, 71, 127-132.
12. Fava GA: Holding on: Depression, sensitization by antidepressant drugs, and the prodigal expert. Psychotherapy and Psychosomatics 1995, 64, 57-61.
13. Fava GA, Rafanelli C, Grandi S, Canestrari R, Morphy MA: Six year outcome for cognitive behavioral treatment symptoms in major depression. American Journal of Psychiatry 1998, 155, 1443-1445.
14. Fava GA, Rafanelli C, Grandi S, Conti S, Belluardo P: Prevention of recurrent depression with cognitive behavioral therapy: Preliminary findings. Archives of General Psychiatry 1998, 55, 816-820.
15. Evans MD, Hollon SD, DeRubeis RJ, Piasecki JM, Grove WM, Garvey MJ, Tuason VB: Differential relapse following cognitive therapy and pharmacotherapy for depression. Archives of General Psychiatry 1992, 49, 802-808.
16. Roth A, Fonagy P: What Works for Whom? A Critical Review of Psychotherapy Research. Guilford, New York, 1996. Trad. it. Psicoterapie e prove di efficacia. Il Pensiero Scientifico Editore, Roma, 1997.
17. Thase M: Mood disorders: Neurobiology. In: Sadock BJ, Sadock VA (Eds.): Kaplan and Sadock's Comprehensive Textbook of Psychiatry, 7th Edition. Lippincott Williams and Wilkins, Baltimore, 2000.
18. Biondi M, Picardi A: Clinical and biological aspects of bereavement and loss-induced depression: A reappraisal. Psychotherapy and Psychosomatics 1996, 65, 229-245.
19. Zisook S, Shuchter SR: Depression through the first year after the death of a spouse. American Journal of Psychiatry 1991, 148, 1346-1352.
20. Jacobs S, Ostfeld A: An epidemiological review of the mortality of bereavement. Psychosomatic Medicine 1977, 39, 344-357.
21. Biondi M: Beyond the brain-mind dichotomy and toward a common organizing principle of pharmacological and psychological treatments. Psychotherapy and Psychosomatics 1995, 64, 1-8.
22. Siegel D: The Developing Mind. Guilford Press, New York, 1999.
23. van der Pompe G, Duivenvoorden HJ, Antoni MH, Visser A, Heijnen CJ. Effectiveness of a short-term group psychotherapy program on endocrine and immune function in breast cancer patients: An exploratory study. Journal of Psychosomatic Research 1997, 42, 453-466.
24. Antoni MH, Cruess S, Cruess DG, Kumar M, Lutgendorf S, Ironson G, Dettmer E, Williams J, Klimas N, Fletcher MA, Schneiderman N. Cognitive-behavioral stress management reduces distress and 24-hour urinary free cortisol output among symptomatic HIV-infected gay men. Annals Behavioral Medicine 2000, 22, 29-37.
25. McKinney CH, Antoni MH, Kumar M, Tims FC, McCabe PM. Effects of guided imagery and music (GIM) therapy on mood and cortisol in healthy adults. Health Psychology 1997, 16, 390-400.
26. McGrady A, Woerner M, Bernal GA, Higgins JT, Jr. Effect of biofeedback-assisted relaxation on blood pressure and cortisol levels in normotensives and hypertensives. Journal of Behavioural Medicine 1987, 10, 301-310.
27. Turner JW, Jr, Fine TH. Effects of relaxation associated with brief restricted environmental stimulation therapy (REST) on plasma cortisol, ACTH, and LH. Biofeedback and Self-Regulation 1983, 8, 115-126.
28. Lokk J, Arnetz B. Psychophysiological concomitants of organizational change in health care personnel: Effects of a controlled intervention study. Psychotherapy and Psychosomatics 1997, 66, 74-77.
29. van der Helm-Hylkema H, Orlebeke JF, Enting LA, Thijssen JH, van Ree J. Effects of behaviour therapy on migraine and plasma beta-endophin in young migraine patients. Psychoneuroendocrinology 1990, 15, 39-45.
30. Cruess DG, Antoni MH, Schneiderman N, Ironson G, McCabe P, Fernandez JB, Cruess SE, Klimas N, Kumar M. Cognitive-behavioral stress management increases free testosterone and decreases psychological distress in HIV-seropositive men. Health Psychology 2000, 19, 12-20.
31. Antoni MH, Cruess DG, Cruess S, Lutgendorf S, Kumar M, Ironson G, Klimas N, Fletcher MA, Schneiderman N. Cognitive-behavioral stress management intervention effects on anxiety, 24hr urinary norepinephrine output, and T-cytotoxic/suppressor cells over time among symptomatic HIV-infected gay men. Journal of Consulting and Clinical Psychology 2000, 68, 31-45.
32. Miller GE, Cohen S. Psychological interventions and the immune system: A meta-analytic review and critique. Health Psychology 2001, 20, 47-63.
33. Martin SD, Martin E, Rai SS, Richardson MA, Royall R. Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: Preliminary findings. Archives of General Psychiatry 2001, 58, 641-648.
34. Brody AL, Saxena S, Stoessel P, Gillies LA, Fairbanks LA, Alborzian S, Phelps ME, Huang SC, Wu HM, Ho ML, Ho MK, Au SC, Maidment K, Baxter LR Jr. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: Preliminary findings. Archives of General Psychiatry 2001, 58, 631-640.
35. Schwartz JM, Stoessel PW, Baxter LR Jr, Martin KM, Phelps ME. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessiveconpulsive disorder. Archives of General Psychiatry 1996, 53, 109-113.
36. Baxter LR Jr, Schwartz JM, Bergman KS, Szuba MP, Guze BH, Mazziotta JC, Alazraki A, Selin CE, Ferng HK, Munford P, et al. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Archives of General Psychiatry 1992, 49, 681-689.
37. Rush AJ. Mood disorders: treatment of depression. In Sadock, B.J. and Sadock, V.A. (Eds.), Kaplan and Sadock's Comprehensive Textbook of Psychiatry, 7th Edition. Lippincott Williams and Wilkins, Baltimore, 2000.
38. Fava GA. Subclinical symptoms in mood disorders: Pathophysiological and therapeutic implications. Psychological Medicine 1999, 29, 47-61.
39. Guidano VF: The Self in Process. Toward a Post-rationalist Cognitive Therapy. New York, Guilford Press, 1991. Trad. it.: Il Sé nel suo divenire. Verso una terapia cognitiva post-razionalista. Boringhieri, Torino, 1992.
40. Basoglu M, Marks IM, Kilic C, Brewin CR, Swinson RP: Alprazolam and exposure for panic disorder with agoraphobia. Attribution of improvement to medication predicts subsequent relapse. British Journal of Psychiatry 1994, 164, 652-659.
41. Biondi M, Picardi A: Attribution of improvement to medication and increased risk of relapse of panic disorder with agoraphobia. Psychoterhapy and Psychosomatics, in corso di stampa.